Cystic fibrosis drug Orkambi 'approved for use among 6-11 year olds'

The pharmaceutical firm making cystic fibrosis drug Orkambi says it has received EU approval to treat children.

Manufacturer Vertex says it will now be suitable for use for those aged 6 to 11.